<DOC>
	<DOCNO>NCT02559349</DOCNO>
	<brief_summary>A pilot , single arm , single center study determine feasibility obtain stool sample adult patient receive SBRT lung tumor , SBRT induce change gut microbiota obtain preliminary data possible correlation baseline composition change gut microbiota tumor response , local control , development pneumonitis/other side effect .</brief_summary>
	<brief_title>Gut Microbiota And Radiotherapy</brief_title>
	<detailed_description />
	<criteria>Patient plan receive Stereotactic Body Radiotherapy ( SBRT ) lung lesion ( either presume biopsyproven NSCLC Age 18 year old old Patient capable give informed consent Exclusion Criteria Use antibiotic , antifungal , antiviral antiparasitics 4 week prior registration Active infection oral temperature &gt; 100Â°F Use corticosteroid , methotrexate immunosuppressive drug 4 week prior registration Use chemotherapy 4 week prior radiotherapy radiotherapy . Chemotherapy begin collection 30day post treatment sample ( S4 ) . Confirmed suspected HIV , HBV HCV Chronic constipation ( bowel movement less frequent every day ) Active uncontrolled gastrointestinal disorder inflammatory bowel disease , moderate/severe irritable bowel syndrome , persistent , infectious gastroenteritis , colitis gastritis , persistent chronic diarrhea unknown etiology , Clostridium Difficile infection ( recurrent ) Helicobacter Pylori infection ( untreated ) Major surgery GI tract , exception cholecystectomy appendectomy , past five year . Any major bowel resection time Patients antidiarrheal medication Patients probiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Stereotactic Body Radiotherapy</keyword>
	<keyword>SBRT</keyword>
</DOC>